The Effect of Uterine Artery Embolization on Premenstrual Symptoms in Patients with Symptomatic Fibroids or Adenomyosis
article
OA: green
CC0
⤵ 3 in-corpus citations
AI-generated summary
This study investigated the impact of uterine artery embolization on premenstrual symptoms in patients diagnosed with symptomatic fibroids or adenomyosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
PurposeTo evaluate whether uterine artery embolization (UAE) can reduce the premenstrual symptoms in women undergoing UAE for fibroid tumors or adenomyosis.Materials and methodsAmong 141 women who underwent UAE for symptomatic fibroid tumors or adenomyosis at a single institution between March 2011 and February 2013, 54 premenstrual symptoms in 39 patients were prospectively analyzed. Premenstrual symptoms were rated by the patient on a scale of 0 to 10, with 0 representing no symptom and 10 representing the baseline severity. The change in premenstrual symptom score was calculated by subtracting the baseline score from the post-UAE score. At 3-6 months after UAE, each woman also completed a symptom severity questionnaire to assess the severity of menstrual bleeding to compare the changes in premenstrual symptoms scores between women with and without menorrhagia.ResultsBack pain, headache, and gastrointestinal symptoms (eg, constipation, indigestion, lower abdominal pain) were significantly improved after UAE (P < .05). Muscle pain, fatigue, nervousness, breast tenderness, and systemic edema were also improved, but not significantly so. The mean premenstrual symptom score change in patients with menorrhagia was significantly greater than in those without menorrhagia (-6.4 vs -3.7; P = .044).There was no correlation between the degree of menorrhagia score change and the degree of premenstrual symptom score change (P = .186).ConclusionsUAE could be a method to alleviate some premenstrual symptoms in patients with uterine fibroid tumors or adenomyosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
- Long-Term Results of Uterine Artery Embolization for Symptomatic Adenomyosis 2006
- Uterine Artery Embolization for Symptomatic Adenomyosis: A New Technical Development of the 1-2-3 Protocol and Predictive Factors of MR Imaging Affecting Outcomes 2011
- Lasting response to ovariectomy in severe intractable premenstrual syndrome 1990
- Endometrial ablation. Improvement in PMS related to the decrease in bleeding. 1992
Cited by (3)
References (34)
- Endometrial ablation. Improvement in PMS related to the decrease in bleeding. via openalex
- Lasting response to ovariectomy in severe intractable premenstrual syndrome via openalex
- Long-Term Results of Uterine Artery Embolization for Symptomatic Adenomyosis via openalex
- Uterine Artery Embolization for Symptomatic Adenomyosis: A New Technical Development of the 1-2-3 Protocol and Predictive Factors of MR Imaging Affecting Outcomes via openalex
- W1987989351 via openalex
- W2017512719 via openalex
- W2027444275 via openalex
- W2036073793 via openalex
- W2055896483 via openalex
- W2059793937 via openalex
- W2070900245 via openalex
- W2077955294 via openalex
- W2093448976 via openalex
- W2097081689 via openalex
- W2101535787 via openalex
- W2109718964 via openalex
- W2112227321 via openalex
- W2114800362 via openalex
- W2129868208 via openalex
- W2134068782 via openalex
- W2134094824 via openalex
- W2139349678 via openalex
- W2144445108 via openalex
- W2155352577 via openalex
- W2329606004 via openalex
- W2425342989 via openalex
- W3012680936 via openalex
- W4254709541 via openalex
- W6604235022 via openalex
- W72141177 via openalex
- W6774910089 via openalex
- W1966846646 via openalex
- W1966926378 via openalex
- W1972695216 via openalex
Cited by (3)
Source provenance
- europepmc
- last seen: 2026-09-04T06:17:57.233406+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:18:35.150238+00:00
License: CC0
· commercial use OK